For the Inventor, By the Inventor

Enter assignee name

Westminster, CO, United States of America

Trisalus Life Sciences, Inc.

USPTO Granted Patents = 13

EPO Patents = 4

Trademarks = 5

Forward Citations = 3

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

James E Chomas (10 out of 58 patents)

Aravind Arepally (8 out of 18 patents)

David Benjamin Jaroch (7 out of 12 patents)

4. Bryan Pinchuk (6 out of 19 patents)

5. Patrick Charles McCain (3 out of 3 patents)

6. Leonard Pinchuk (2 out of 148 patents)

7. Robert A Kastelein (1 out of 62 patents)

8. Robert L Coffman (1 out of 29 patents)

9. John B Martin (1 out of 26 patents)

10. Jennifer D Lucky (1 out of 1 patent)

11. Dino Dina (1 out of 38 patents)

12. Jason Marshall (1 out of 6 patents)

13. Andrew Evan Denker (1 out of 7 patents)

14. Brett E Naglreiter (1 out of 35 patents)

15. Ying Yu (1 out of 2 patents)

13 patents: Sort by Forward Citations

1. 12502479 - Closed tip dynamic microvalve protection device (2025-12-23),

2. 12472052 - Dynamic microvalve protection device (2025-11-18),

3. 12433597 - Atraumatic occlusive system with compartment for measurement of vascular pressure change (2025-10-07),

4. 12390621 - System and method for selective pressure-controlled therapeutic delivery (2025-08-19),

5. 12377245 - Method of delivering a therapeutic agent to a solid tumor for treatment (2025-08-05),

6. 12226604 - Dual pathway therapeutic agent delivery (2025-02-18),

7. 12201508 - Dynamic microvalve protection device (2025-01-21),

8. 12138424 - Closed tip dynamic microvalve protection device (2024-11-12),

9. 11918648 - Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer (2024-03-05),

10. 11850398 - Systems and methods for pressure-facilitated therapeutic agent delivery (2023-12-26),

11. 11400263 - System and method for selective pressure-controlled therapeutic delivery (2022-08-02),

12. 11338117 - Implantable dual pathway therapeutic agent delivery port (2022-05-24),

13. 11312965 - Immunostimulatory sequence oligonucleotides and methods of using the same (2022-04-26),

Trisalus Life Sciences, Inc. is a medical technology company focused on developing innovative solutions for liver cancer treatment. Their mission is to improve patient outcomes by providing minimally invasive and effective treatment options. With a team of experienced professionals, Trisalus is dedicated to revolutionizing the way liver cancer is treated. Visit their website to learn more about their cutting-edge technologies and solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

13 Patents

#12 in Westminster, CO

#464 in Colorado

#23,104 in US

#43,644 in the World

Westminster, CO, United States of America

Trisalus Life Sciences, Inc.

Forward Citations = 3

24 inventors:

James E Chomas (10 out of 58 patents)

Aravind Arepally (8 out of 18 patents)

David Benjamin Jaroch (7 out of 12 patents)

4. Bryan Pinchuk (6 out of 19 patents)

5. Patrick Charles McCain (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…